Tirzepertide

Tirzepatide is a relatively new medication used for managing type 2 diabetes and, more recently, for weight management. It is a dual GLP-1 and GIP receptor agonist, which means it works by mimicking two hormones (GLP-1 and GIP) that regulate blood sugar levels and appetite.

Tirzepatide works by activating two hormone receptors: GLP-1 (glucagon-like      peptide-1) and GIP (gastric inhibitory peptide). These hormones help:

    Stimulate insulin secretion in response to meals.

    Suppress glucagon release (which prevents the liver from making too much glucose)

    Slow gastric emptying, which reduces appetite and food intake.

Tirzepatide is administered as a subcutaneous injection (under the skin). It is      typically injected once a week, and the dosage is adjusted based on individual needs and tolerability.

Some common side effects may include: 

Nausea

Diarrhea

Vomiting

Loss of appetite

Constipation

Abdominal pain

These side effects tend to be more common when starting the medication and may      decrease over time.

Tirzepatide is not recommended for:

People with a personal or family history of medullary thyroid carcinoma (a rare type of thyroid cancer).

People with Multiple Endocrine Neoplasia syndrome type 2 (a genetic disorder).

Those who are allergic to tirzepatide or any of its ingredients.

It should also be used with caution in people with a history of pancreatitis.

Yes, Tirzepatide has been shown to help with weight loss in patients with type 2 diabetes and those who are overweight or obese. It reduces appetite and promotes a feeling of fullness, which can lead to reduced calorie intake.

The starting dose is usually 2.5 mg once a week, which can be gradually increased based on the patient's needs and how they tolerate the medication. Common dose adjustments are 5 mg, 7.5 mg, 10 mg, and up to 15mg weekly.

Coverage for Tirzepatide depends on your insurance plan. It's more likely to be covered for people with type 2 diabetes. If you're using Semaglutide for weight loss, insurance coverage may be more limited. Always check with your provider or insurance company to understand your coverage.  However, our practice is a cash base practice bringing these medications to our patients for fraction of the cost that branded medications are being sold for. 

 When discussing medications, there is usually a generic name and a Brand name. 

In this case:

• Tirzepatide- is the generic name
• Mounjaro- is a Brand name
• Zepbound- is a Brand name

All of the medications are essentially the same and have the active ingredients.